PharmaCyte Biotech, Inc. (PMCB) › Total AssetsPharmaCyte Biotech, Inc. (PMCB) — Total AssetsAnnual figures by fiscal year, from SEC filings.2011: $1.24M2012: $2.09M2013: $2.88M2014: $9.32M2015: $9.30M2016: $7.16M2017: $8.67M2018: $6.41M2019: $5.78M2020: $6.17M2021: $7.40M2022: $90.62M2023: $73.28M2024: $59.90M2025: $55.17M$55.17M2011Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$55.17M-7.9%2024$59.90M-18.3%2023$73.28M-19.1%2022$90.62M+1124.0%2021$7.40M+20.1%2020$6.17M+6.6%2019$5.78M-9.8%2018$6.41M-26.0%2017$8.67M+21.0%2016$7.16M-23.0%2015$9.30M-0.2%2014$9.32M+223.8%2013$2.88M+37.8%2012$2.09M+68.3%2011$1.24M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share